Single User License
INR 169825
Site License
INR 339650
Corporate User License
INR 509475

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Human Papillomavirus Infections Global Clinical Trials Review, H1

Human Papillomavirus Infections Global Clinical Trials Review, H1


  Request for Sample Report

Executive Summary

Human Papillomavirus Infections Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Human Papillomavirus Infections Global Clinical Trials Review, H1, 2015" provides an overview of Human Papillomavirus Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Human Papillomavirus Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Human Papillomavirus Infections 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Human Papillomavirus Infections to Infectious Disease Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Human Papillomavirus Infections to Infectious Disease Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Human Papillomavirus Infections 25

Subjects Recruited Over a Period of Time 28

Clinical Trials by Sponsor Type 29

Prominent Sponsors 30

Top Companies Participating in Human Papillomavirus Infections Therapeutics Clinical Trials 31

Prominent Drugs 32

Latest Clinical Trials News on Human Papillomavirus Infections 33

Jun 16, 2015: Genticel Receives FDA Clearance of IND Application for U.S. Phase 1 Clinical Trial of GTL001, Company's First-in-class HPV Therapeutic Vaccine Candidate 33

Apr 20, 2015: Genticel to Present Further Promising Pharmacology In-Vivo Results of Its Phase 2 Immunotherapeutic Vaccine Candidate, GTL001 (ProCervix), at AACR Annual Meeting 2015 33

Clinical Trial Profiles 34

Clinical Trial Overview of Top Companies 34

GlaxoSmithKline Plc 34

Clinical Trial Overview of GlaxoSmithKline Plc 34

Merck & Co., Inc. 39

Clinical Trial Overview of Merck & Co., Inc. 39

Merck Sharp & Dohme Corp. 42

Clinical Trial Overview of Merck Sharp & Dohme Corp. 42

Valeant Pharmaceuticals International, Inc. 45

Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 45

Medicis Pharmaceutical Corporation 46

Clinical Trial Overview of Medicis Pharmaceutical Corporation 46

Genticel S.A. 47

Clinical Trial Overview of Genticel S.A. 47

Nestle S.A. 48

Clinical Trial Overview of Nestle S.A. 48

BioMAS Ltd. 49

Clinical Trial Overview of BioMAS Ltd. 49

AstraZeneca Plc 50

Clinical Trial Overview of AstraZeneca Plc 50

Akela Pharma Inc. (Inactive) 51

Clinical Trial Overview of Akela Pharma Inc. (Inactive) 51

Clinical Trial Overview of Top Institutes / Government 52

The National Institute of Allergy and Infectious Diseases 52

Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 52

National Cancer Institute 53

Clinical Trial Overview of National Cancer Institute 53

AIDS Malignancy Clinical Trials Consortium 55

Clinical Trial Overview of AIDS Malignancy Clinical Trials Consortium 55

Leiden University Medical Center 56

Clinical Trial Overview of Leiden University Medical Center 56

Medical University of Vienna 57

Clinical Trial Overview of Medical University of Vienna 57

Dana-Farber Cancer Institute, Inc. 58

Clinical Trial Overview of Dana-Farber Cancer Institute, Inc. 58

Duke University 59

Clinical Trial Overview of Duke University 59

Second Affiliated Hospital of Shanxi Medical University 60

Clinical Trial Overview of Second Affiliated Hospital of Shanxi Medical University 60

Shiraz University of Medical Sciences 61

Clinical Trial Overview of Shiraz University of Medical Sciences 61

The Johns Hopkins University 62

Clinical Trial Overview of The Johns Hopkins University 62

Five Key Clinical Profiles 63

Appendix 117

Abbreviations 117

Definitions 117

Research Methodology 118

Secondary Research 118

About GlobalData 119

Contact Us 119

Disclaimer 119

Source 120

List of Figures

Human Papillomavirus Infections Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Human Papillomavirus Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Human Papillomavirus Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Human Papillomavirus Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Human Papillomavirus Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Human Papillomavirus Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Human Papillomavirus Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Human Papillomavirus Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14

Proportion of Human Papillomavirus Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15

Human Papillomavirus Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Human Papillomavirus Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Human Papillomavirus Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18

Human Papillomavirus Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Human Papillomavirus Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Human Papillomavirus Infections Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Human Papillomavirus Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Human Papillomavirus Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Human Papillomavirus Infections Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Human Papillomavirus Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Human Papillomavirus Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29

Human Papillomavirus Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Human Papillomavirus Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Human Papillomavirus Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

GlobalData Methodology 118

List of Tables

Human Papillomavirus Infections Therapeutics, Global, Clinical Trials by Region, 2015* 7

Human Papillomavirus Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Human Papillomavirus Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Human Papillomavirus Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Human Papillomavirus Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Human Papillomavirus Infections Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Human Papillomavirus Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Human Papillomavirus Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14

Proportion of Human Papillomavirus Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15

Human Papillomavirus Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Human Papillomavirus Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Human Papillomavirus Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18

Human Papillomavirus Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Human Papillomavirus Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Human Papillomavirus Infections Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Human Papillomavirus Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Human Papillomavirus Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Human Papillomavirus Infections Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Human Papillomavirus Infections Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Human Papillomavirus Infections Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Human Papillomavirus Infections Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Human Papillomavirus Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Human Papillomavirus Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29

Human Papillomavirus Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Human Papillomavirus Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Human Papillomavirus Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 34

Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 39

Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck Sharp & Dohme Corp., 2015* 42

Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015* 45

Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Medicis Pharmaceutical Corporation, 2015* 46

Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Genticel S.A., 2015* 47

Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Nestle S.A., 2015* 48

Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by BioMAS Ltd., 2015* 49

Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015* 50

Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Akela Pharma Inc. (Inactive), 2015* 51

Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015* 52

Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 53

Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by AIDS Malignancy Clinical Trials Consortium, 2015* 55

Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2015* 56

Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015* 57

Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, Inc., 2015* 58

Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015* 59

Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Second Affiliated Hospital of Shanxi Medical University, 2015* 60

Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2015* 61

Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The Johns Hopkins University, 2015* 62

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

GlaxoSmithKline Plc

Merck & Co., Inc.

Merck Sharp & Dohme Corp

Valeant Pharmaceuticals International, Inc.

Medicis Pharmaceutical Corporation

Genticel S.A.

Nestle S.A.

BioMAS Ltd.

AstraZeneca Plc

Human Papillomavirus Infections Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Human Papillomavirus Infections, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com